Download Full Text (522 KB)
In the United States, 34.2 million people are currently diagnosed with diabetes mellitus, which accounts for 10.5% of the total population.1 Type 2 diabetes mellitus (T2DM) holds 94.2% of all diabetes diagnoses. The American Association of Diabetes estimates approximately $327 billion annually and is broken up as follows:1
tirzepatide, GLP-1 receptor agonists, type-2 diabetes
Medicine and Health Sciences | Nephrology
LaPlante, Madison, "The Effectiveness of Tirzepatide (GIP/GLP-1 Receptor co-Agonist) vs GLP-1 Receptor Agonists on Lowering A1C in Adults with Type 2 Diabetes Mellitus" (2023). Master of Science in Physician Assistant Studies Capstone Presentations (Center City). 16.